Maze Therapeutics
MAZE
#5033
Rank
A$2.65 B
Marketcap
A$48.53
Share price
3.94%
Change (1 day)
-11.37%
Change (1 year)

EPS for Maze Therapeutics (MAZE)

EPS in 2026 (TTM): A-$3.72

According to Maze Therapeutics's latest financial reports the company's current EPS (TTM) is A-$3.77. In 2025 the company made an earnings per share (EPS) of A-$4.83 a decrease over its 2024 EPS that were of A-$3.28.

EPS history for Maze Therapeutics from 2024 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$3.72-23.08%
2025A-$4.8347.54%
2024A-$3.28